Track the Laboratorios Farmaceuticos Rovi, S.A. share price and the full insider trade history of the company, a listed issuer based in Spain. Shares trade on the ES market, under the authority of CNMV. Operating in the Health Care sector, Laboratorios Farmaceuticos Rovi, S.A. has logged 14 reports. Market capitalisation: €2.9bn. The latest transaction was filed on 23 June 2023 (Purchase). Among the most active insiders: NORBEL INVERSIONES, S.L.. All data is free.
14
Insider Decl.
n/a
Thresholds
€2m
2 ops.
Buy Volume
€342m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Laboratorios Farmaceuticos Rovi, S.A. Buy (bullish), based on 9 analysts. Average price target: €73.82.
25Σ signal
Buys €2m€342m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,713 of 28,855 companies
69.2
score / 100
Value
55
Quality
84
FCF yld4.0%
Earn yld4.7%
EV/EBITDA14.3x
ROE29%
Gross mgn65%
Net mgn19%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,682,069 shares@ €52.25100.0% of flowShareXXXXISINISIN ES0157261019CNMV:2021088921
14 of 14 declarations
About Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. is a Spanish pharmaceutical company focused on the development and commercialization of medications. It is listed on the Spanish stock market, XMAD.